EQUAL CARE has launched its first evidence register with analysis of 170 active substances. The health-tech company is developing structured data sets for sex- and gender-specific medicine.
Research shows that biological and gender-related factors influence symptoms, diagnosis, disease progression, treatment response, and adverse events.
“Sex-relevant information is currently distributed across multiple sections of regulated documents, and the terminology differs substantially from one drug class to another,” said Thao Nguyen, CEO and Co-Founder of EQUAL CARE. “Without a shared structure, it becomes nearly impossible to analyse these details systematically and that’s exactly what we’re solving.”
EQUAL CARE does not generate new clinical data or interpret risk but provides technical infrastructure to organize and access what already exists. The register uses three pillars: structured data, transparent traceability, and scalable automation.
“Much of the information relevant to sex- and gender-informed medicine already exists but not in a form that allows structured analysis,” said Dr. Simone Braun, physician and Co-Founder of EQUAL CARE. “With this register, we are creating the groundwork for research, digital health solutions, and evidence-based HealthTech that can better reflect biological and gender-related differences.”
The register aims to support improvements in diagnostics, clinical decision support, personalized therapies, and digital women’s health tools. Regulatory initiatives including the EU AI Act, the European Health Data Space, and international efforts to advance sex- and gender-sensitive research point toward transparency, fairness, and standardized data structures in health technology.
EQUAL CARE will expand the register throughout 2026, with the aim of covering several thousand active substances and offering APIs for research, pharmaceutical development, and transparency frameworks.
EQUAL CARE was founded by Thao Nguyen, Dr. Simone Braun, and Ioana Freise. The company has offices in Switzerland and Germany.
